The benchmark indices saw a correction for the first time in the last four consecutive sessions, with the Nifty 50 falling half a percent on January 17 despite positive market breadth. A total of 1,296 shares saw buying interest, against 1,220 shares that were corrected on the NSE. The market is expected to sustain range-bound trading, and the elevated volatility signals caution for bulls. Below a...

The benchmark indices continued to trade higher for the third consecutive session on January 17, with the Nifty 50 rising 0.4 percent. The market breadth was positive, as about 1,891 shares saw buying interest against 620 declining shares on the NSE. The market is expected to consolidate as long as it trades below all key moving averages. Below are some trading ideas for the near term:Chandan Tapa...

The benchmark indices maintained their upward journey, with the Nifty advancing by 0.2 percent amid volatility on January 15, while the market breadth favored the bulls. A total of 1,371 shares advanced, compared to 1,144 shares that saw a correction on the NSE. The rangebound trade may continue until the frontline indices decisively break Monday's high. Below are some trading ideas for the near t...

Shares of Biocon surged over 4 percent on January 14 after brokerage firm HSBC upgraded the stock to a 'buy' call amid expectations of a turnaround for the drugmaker. HSBC also lifted its price target for the stock by nearly half to Rs 430 to factor in its growth potential.At 10.16 am, shares of Biocon were trading at Rs 375.30 on the NSE, extending gains to the second session.After the clearance ...

The benchmark indices closed at a seven-month low, extending their downtrend for the fourth consecutive session, declining over 1.4% on January 13, with negative market breadth. A total of 2,373 equity shares saw a correction, compared to 212 shares that gained on the NSE. The market may attempt a rebound amid likely consolidation; however, the overall sentiment remains bearish. Below are some tra...